Effectiveness and Safety of Trabectedin and Radiotherapy for Patients With Myxoid Liposarcoma
2023; American Medical Association; Volume: 9; Issue: 5 Linguagem: Inglês
10.1001/jamaoncol.2023.0056
ISSN2374-2445
AutoresRoberta Sanfilippo, Nadia Hindi, Josefina Cruz Jurado, Jean‐Yves Blay, Antonio López‐Pousa, Antoîne Italiano, Rosa Álvarez, Antonio Gutiérrez, Inmaculada Rincon-Pérez, Claudia Sangalli, Jose Luis Pérez Aguiar, Jesús Romero, Carlo Morosi, Marie‐Pierre Sunyach, Chiara Fabbroni, Cleofé Romagosa, Dominique Ranchère‐Vince, Angelo Paolo Dei Tos, Paolo G. Casali, Javier Martín‐Broto, Alessandro Gronchi,
Tópico(s)Musculoskeletal synovial abnormalities and treatments
ResumoPreclinical data about the synergistic activity of radiotherapy (RT) and trabectedin have been reported. The combination of trabectedin and RT in treating myxoid liposarcomas appears worth exploring.
Referência(s)